electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11
Domestic: | 877-407-4018 |
International: | 201-689-8471 |
Conference ID: | 13715729 |
Webcast: | http://public.viavid.com/index.php?id=143276 |
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.
For more information, visit www.electrocore.com.
Investors:
617-430-7578
hans@lifesciadvisors.com
or
Media Contact:
electroCore
973-290-0097
summer.diaz@electrocore.com